INREBIC
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 12 Sept 2025)
What this means for you
Registered since 14 Jan 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88207119
- Registration number
- 5962898
- Mark type
- Design + words
- Filed
- 27 Nov 2018
- Published for opposition
- 09 Apr 2019
- Registered
- 14 Jan 2020
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the treatment of myeloproliferative diseases, myelofibrosis, autoinflammatory disease, autoimmune disease, blood disease, cancer in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
Owner
- IMPACT BIOMEDICINES, INC., Summit, NJ, US
- IMPACT BIOMEDICINES, INC., SUMMIT, NJ, US
- IMPACT BIOMEDICINES, INC., SUMMIT, NJ, US
- Celgene Corporation, Summit, NJ, US
Prior registrations
Prosecution history
- 12 Sept 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 12 Sept 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 11 Sept 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 01 May 2025 — TEAS SECTION 8 & 15 RECEIVED
- 14 Jan 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 09 Dec 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 09 Dec 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Dec 2022 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 09 Dec 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 09 Dec 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Dec 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 14 Jan 2020 — REGISTERED-PRINCIPAL REGISTER
- 07 Dec 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Dec 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Dec 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED